These findings support the hypothesis that sustained treatment with mild Nrf2 inducers, such as 6-MSITC, may prevent the onset of cognitive impairment in a murine model of Alzheimer’s disease [38]. This evidence concerns the gene NFE2L2 and Alzheimer disease.